AU2002350832A1 - Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension - Google Patents

Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension

Info

Publication number: AU2002350832A1
Authority: AU; Australia
Prior art keywords: irbesartan; medicaments; preparation; prevent; pulmonary hypertension
Prior art date: 2001-10-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002350832A

Other versions

AU2002350832B2 (en

Inventor

Sylvie Cosnier-Pucheu

Dino Nisato

Alain Roccon

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sanofi Aventis France

Original Assignee

Sanofi Aventis France

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-26

Filing date

2002-10-09

Publication date

2003-07-03

2001-10-26 Priority claimed from FR0113936A external-priority patent/FR2831446B1/en

2002-10-09 Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France

2003-07-03 Publication of AU2002350832A1 publication Critical patent/AU2002350832A1/en

2005-02-17 Assigned to SANOFI-AVENTIS reassignment SANOFI-AVENTIS Amend patent request/document other than specification (104) Assignors: SANOFI-SYNTHELABO

2006-11-30 Application granted granted Critical

2006-11-30 Publication of AU2002350832B2 publication Critical patent/AU2002350832B2/en

2022-10-09 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

AU2002350832A 2001-10-26 2002-10-09 Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension Ceased AU2002350832B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
FR0113936A FR2831446B1 (en)	2001-10-26	2001-10-26	USE OF IRBESARTAN FOR THE PREPARATION OF MEDICINES USEFUL FOR THE PREVENTION OR TREATMENT OF PULMONARY HYPERTENSION
FR01/13936		2001-10-26
PCT/FR2002/003439 WO2003035062A1 (en)	2001-10-26	2002-10-09	Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension

Publications (2)

Publication Number	Publication Date
AU2002350832A1 true AU2002350832A1 (en)	2003-07-03
AU2002350832B2 AU2002350832B2 (en)	2006-11-30

Family

ID=8868812

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002350832A Ceased AU2002350832B2 (en)	2001-10-26	2002-10-09	Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension

Country Status (24)

Country	Link
US (2)	US20040242567A1 (en)
EP (1)	EP1441723B1 (en)
JP (1)	JP4542777B2 (en)
CN (1)	CN100418526C (en)
AT (1)	ATE361071T1 (en)
AU (1)	AU2002350832B2 (en)
BR (1)	BR0213479A (en)
CA (1)	CA2461625C (en)
CY (1)	CY1106746T1 (en)
DE (1)	DE60219940T2 (en)
DK (1)	DK1441723T3 (en)
EA (1)	EA007952B1 (en)
ES (1)	ES2286304T3 (en)
FR (1)	FR2831446B1 (en)
HU (1)	HUP0401633A3 (en)
IL (2)	IL161116A0 (en)
IS (1)	IS2849B (en)
MX (1)	MXPA04003910A (en)
NO (1)	NO332313B1 (en)
NZ (1)	NZ532130A (en)
PL (1)	PL209263B1 (en)
PT (1)	PT1441723E (en)
WO (1)	WO2003035062A1 (en)
ZA (1)	ZA200402696B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8912174B2 (en)	2003-04-16	2014-12-16	Mylan Pharmaceuticals Inc.	Formulations and methods for treating rhinosinusitis
US7811606B2 (en)	2003-04-16	2010-10-12	Dey, L.P.	Nasal pharmaceutical formulations and methods of using the same
US9808471B2 (en)	2003-04-16	2017-11-07	Mylan Specialty Lp	Nasal pharmaceutical formulations and methods of using the same
US20040265238A1 (en) *	2003-06-27	2004-12-30	Imtiaz Chaudry	Inhalable formulations for treating pulmonary hypertension and methods of using same
TR200301553A1 (en) *	2003-09-18	2005-10-21	Nobel �La� Sanay�� Ve T�Caret A.�.	New oral pharmaceutical formulations containing irbesartan active ingredient
CA2568640C (en)	2004-06-04	2011-08-09	Teva Pharmaceutical Industries Ltd.	Pharmaceutical composition containing irbesartan
WO2006067601A1 (en) *	2004-12-23	2006-06-29	Ranbaxy Laboratories Limited	Oral pharmaceutical compositions of irbesartan and hydrochlorothiazide and processes for their preparation
CN100367959C (en) *	2006-08-29	2008-02-13	陈俊云	Medicine contg. irbesartan
GB0617171D0 (en) *	2006-08-31	2006-10-11	Generics Uk Ltd	Novel compositions and methods
US20240173302A1 (en) *	2021-03-23	2024-05-30	Dimerix Bioscience Pty Ltd	Treatment of inflammatory diseases

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5258510A (en) *	1989-10-20	1993-11-02	Otsuka Pharma Co Ltd	Benzoheterocyclic compounds
US5270317A (en) *	1990-03-20	1993-12-14	Elf Sanofi	N-substituted heterocyclic derivatives, their preparation and the pharmaceutical compositions in which they are present
TW201738B (en) *	1990-03-20	1993-03-11	Sanofi Co
RU2086544C1 (en) *	1991-06-13	1997-08-10	Хоффманн-Ля Рош АГ	Benzenesulfonamide derivatives of pyrimidine or their salts, pharmaceutical composition for treatment of diseases associated with endothelin activity
US5292741A (en) *	1992-08-18	1994-03-08	Merck & Co., Inc.	Macrocycles incorporating quinazolinones
US20020068740A1 (en)	1999-12-07	2002-06-06	Mylari Banavara L.	Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications

2001
- 2001-10-26 FR FR0113936A patent/FR2831446B1/en not_active Expired - Fee Related
2002
- 2002-10-09 CA CA2461625A patent/CA2461625C/en not_active Expired - Fee Related
- 2002-10-09 PT PT02785535T patent/PT1441723E/en unknown
- 2002-10-09 AT AT02785535T patent/ATE361071T1/en active
- 2002-10-09 DK DK02785535T patent/DK1441723T3/en active
- 2002-10-09 NZ NZ532130A patent/NZ532130A/en not_active IP Right Cessation
- 2002-10-09 HU HU0401633A patent/HUP0401633A3/en unknown
- 2002-10-09 EP EP02785535A patent/EP1441723B1/en not_active Expired - Lifetime
- 2002-10-09 ES ES02785535T patent/ES2286304T3/en not_active Expired - Lifetime
- 2002-10-09 WO PCT/FR2002/003439 patent/WO2003035062A1/en not_active Ceased
- 2002-10-09 CN CNB028213041A patent/CN100418526C/en not_active Expired - Fee Related
- 2002-10-09 MX MXPA04003910A patent/MXPA04003910A/en active IP Right Grant
- 2002-10-09 PL PL368737A patent/PL209263B1/en unknown
- 2002-10-09 JP JP2003537629A patent/JP4542777B2/en not_active Expired - Fee Related
- 2002-10-09 AU AU2002350832A patent/AU2002350832B2/en not_active Ceased
- 2002-10-09 US US10/492,804 patent/US20040242567A1/en not_active Abandoned
- 2002-10-09 BR BR0213479-9A patent/BR0213479A/en not_active Application Discontinuation
- 2002-10-09 EA EA200400438A patent/EA007952B1/en not_active IP Right Cessation
- 2002-10-09 IL IL16111602A patent/IL161116A0/en unknown
- 2002-10-09 DE DE60219940T patent/DE60219940T2/en not_active Expired - Lifetime
2004
- 2004-03-25 IL IL161116A patent/IL161116A/en not_active IP Right Cessation
- 2004-03-29 IS IS7200A patent/IS2849B/en unknown
- 2004-04-06 ZA ZA2004/02696A patent/ZA200402696B/en unknown
- 2004-04-23 NO NO20041732A patent/NO332313B1/en not_active IP Right Cessation
2007
- 2007-07-19 CY CY20071100964T patent/CY1106746T1/en unknown
2009
- 2009-06-03 US US12/477,562 patent/US8088827B2/en not_active Expired - Fee Related

Similar Documents

Publication	Publication Date	Title
WO2003048081A3 (en)	2003-09-12	Glycinamides as factor xa inhibitors
AU2002305205A1 (en)	2002-11-05	9-deazaguanine derivatives as inhibitors of gsk-3
HUP0401514A3 (en)	2012-08-28	Pharmaceutical compositions for the treatment of asthma
AU2003219100A1 (en)	2003-10-08	Pyrazolopyridazine derivatives, process for preparation and use for the inhibition of gsk-3
AU2002240359A1 (en)	2002-08-28	Pharmaceutical composition for the treatment of alopecia
AU2003258145A1 (en)	2004-02-25	Substituted phenylindoles for the treatment of hiv
AU2002233928A1 (en)	2002-07-01	Cycloalkylfused (g)-indole compounds as spla2-inhibitors in the treatment of inflammatory diseases
AU2003290059A1 (en)	2004-07-09	Use of cd137 antagonists for the treatment of tumors
AU2002350832A1 (en)	2003-07-03	Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
HUP0401633A3 (en)	2009-06-29	Use of irbesartan for the preparation of pharmaceutical compositions that are used to prevent or treat pulmonary hypertension
AU2002362505A1 (en)	2003-04-14	Compression sleeve for treatment of the extremities
AU2003260983A1 (en)	2004-04-30	Processes for the preparation of s-(-)-amlodipine
AU2003289652A1 (en)	2004-07-09	The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion
AU2002249947A1 (en)	2002-07-30	Inhibition of protein-phosphatases for the treatment of heart failure
AU2003220026A1 (en)	2003-09-16	Methods and compositions for the treatment of ischemia
AU2001274022A1 (en)	2002-02-21	Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2003269257A1 (en)	2004-05-04	Use of cap-1 for the therapy of asthma
HK1065488A (en)	2005-02-25	Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
AU2002221566A1 (en)	2002-07-01	Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders
SI1441723T1 (en)	2007-10-31	Use of irbesartan for the preparation of medicaments that are used to prevent or treat pulmonary hypertension
AU2003240174A1 (en)	2003-12-22	Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2002251202A1 (en)	2002-10-15	Intimins for the prevention or treatment of infections: i
WO2005105799A8 (en)	2006-07-06	Dialkoxy-imidazopyridines derivatives
AU2002350387A1 (en)	2003-05-19	Pna-conjugate or pna-conjugate mixture for treating diseases related to the human papillomavirus
AU2002249232A1 (en)	2002-09-04	Use of $g(g)-gt inhibitors for the treatment of degenerative diseases